Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Author: Avi Kapoor | July 01, 2025 11:44am

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • JP Morgan analyst Joseph Greff upgraded Melco Resorts & Entertainment Limited (NASDAQ:MLCO) from Neutral to Overweight and raised the price target from $7.2 to $9.5. Melco Resorts shares closed at $7.23 on Monday. See how other analysts view this stock.
  • Barclays analyst Gena Wang upgraded the rating for Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) from Equal-Weight to Overweight and boosted the price target from $51 to $57. Ionis Pharmaceuticals shares closed at $39.51 on Monday. See how other analysts view this stock.
  • Wolfe Research analyst Scott Group upgraded the rating for C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) from Peer Perform to Outperform. C.H. Robinson shares closed at $95.95 on Monday. See how other analysts view this stock.
  • Wells Fargo analyst Jason Haas upgraded Cintas Corporation (NASDAQ:CTAS) from Underweight to Equal-Weight and raised the price target from $196 to $221. Cintas shares closed at $222.87 on Monday. See how other analysts view this stock.
  • Argus Research analyst John Staszak upgraded the rating for Nike, Inc. (NYSE:NKE) from Hold to Buy and maintained the price target of $85. Nike shares closed at $71.04 on Monday. See how other analysts view this stock.

Considering buying NKE stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Posted In: CHRW CTAS IONS MLCO NKE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist